Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 10/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 4/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18822335 | 0.83 | GRIN1 (0.48) | SLC6A9OPRM1SLC6A5OPRL1POLB | |
| SCHEMBL21945182 | 0.79 | GRIN1 (0.40) | OPRM1OPRL1 | |
| SCHEMBL18794837 | 0.79 | SLC6A9 (0.38) | HSD11B1SLC6A9OPRM1KCNH2SLC6A3 | |
| SCHEMBL2307237 | 0.75 | GRIN1 (0.39) | HSD11B1SLC6A9OPRM1KCNH2SLC6A3 | |
| SCHEMBL31068526 | 0.74 | CA12 (0.36) | — | |
| SCHEMBL2309479 | 0.70 | DAO (0.39) | HSD11B1SLC6A9OPRM1KCNH2SLC6A3 | |
| SCHEMBL14140547 | 0.67 | CCR2 (0.38) | — | |
| SCHEMBL31730194 | 0.67 | RAB9A (0.42) | POLB | |
| SCHEMBL22540358 | 0.67 | SLC6A4 (0.40) | OPRM1OPRL1SLC6A3 | |
| SCHEMBL1239660 | 0.67 | DRD2 (0.40) | HSD11B1OPRM1OPRL1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017070793-A1 | NOVEL FLUORINATED HETEROCYCLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS | TRILLIUM THERAPEUTICS INC. (CA) | 2017-05-04 | — | — | WO | disclosed |
| WO-2017070793-A1 | NOVEL FLUORINATED HETEROCYCLE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS | TRILLIUM THERAPEUTICS INC. (CA) | 2017-05-04 | — | — | WO | disclosed |